Sign in
Taking people in United StatesNo phase

Registry following teenagers with severe alopecia areata during routine care

Tracks safety and effectiveness of treatments in teenagers with severe alopecia areata.

Key facts

Who runs it
CorEvitas
Where
Waltham, United StatesSee the site
Trial code
Registry title
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Status
Recruiting
People taking part
1,500 people, planned
Started
7 Mar 2024
Expected to end
31 Dec 2099
Type of study
Observational
Record updated
17 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for teenagers aged 12-17 who have ever been diagnosed with severe alopecia areata (patchy hair loss). It is a registry that follows their routine care.

Age
12 to 17 years
Sex
All sexes
Disease stage
Severe alopecia areata, diagnosed at any time by a dermatologist or a qualified healthcare provider

Main reasons for not taking part

  • Taking part, or planning to take part, in a blinded clinical trial of any investigational medicine
  • Unwilling or unable to have standing height measured

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • To be eligible to participate in this registry, an individual must meet all the following criteria:
  • Has ever been diagnosed with severe AA by a dermatologist or a qualified healthcare provider
  • Is 12-17 years of age at the time of enrollment
  • Is willing to provide consent/assent for participation in the registry

Who cannot take part

  • Is participating or planning to participate in a blinded clinical trial for any investigational medication
  • An individual who meets any of the following criteria will be excluded from participation in the registry:
  • Is unwilling or unable to provide standing height measurements

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 17 years old?

Where in United States

  • CorEvitas, LLCWaltham, United StatesContact: Cathy CheneyTaking people

About the trial

What the trial wants to find out

Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Plain-language title
Registry following teenagers with severe alopecia areata during routine careGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06562270, who can take part
Record updated
17 August 2026